As we delve deep into countless medical journals to uncover the latest on Integrative Medicine’s approach to kidney health, we are always reminded of the value of your time. Our commitment remains steadfast in curating and succinctly summarizing these vital studies for you. Welcome to the March Research and News.
When Alkaline Phosphatase Fluctuates, CKD Outcomes Worsen
This large retrospective cohort study analyzed more than 14,000 patients with chronic kidney disease to determine whether alkaline phosphatase (ALP) levels and their variability predict long-term outcomes.
Higher baseline ALP levels were associated with significantly increased risks of both all-cause mortality and progression to end-stage kidney disease.
Importantly, fluctuations in ALP over time also carried prognostic value: patients with the greatest variability had markedly higher mortality risk compared with those whose ALP levels remained stable.
These associations persisted across major comorbid conditions including diabetes, hypertension, and cardiovascular disease.
Why is this important?
The findings suggest that ALP is not only a static risk marker but that instability in ALP levels may signal underlying metabolic bone disease, inflammation, or vascular calcification processes that accelerate CKD progression and mortality.
Monitoring trends in ALP over time—not just single measurements—may therefore provide a simple clinical tool for identifying higher-risk CKD patients and guiding closer follow-up or targeted interventions.
Air Pollution May Directly Damage the Kidneys
This Mendelian randomization study used genetic data from large genome-wide association studies to investigate whether exposure to air pollution causally affects kidney function.
The analysis showed that exposure to coarse particulate matter (PM2.5–10) was significantly associated with a higher risk of chronic kidney disease and lower kidney function measured by both creatinine-based and cystatin C–based eGFR.
Nitrogen oxides were also linked to reduced kidney function, while nitrogen dioxide exposure was associated with higher urine albumin-to-creatinine ratios, indicating kidney damage.
Interestingly, fine particulate matter (PM2.5) and larger particles (PM10) alone did not show significant associations in this analysis.
Why is this important?
Because Mendelian randomization helps infer causality, these findings strengthen the evidence that air pollution is not merely correlated with kidney disease but may directly contribute to kidney injury and CKD development.
The results highlight environmental pollution as a potentially modifiable risk factor for kidney disease and support public health strategies aimed at reducing air pollution exposure to protect kidney health.
Higher Serum Osmolality Signals Faster Kidney Decline in ADPKD
This prospective study followed 311 patients with autosomal dominant polycystic kidney disease who were not treated with tolvaptan to evaluate whether serum and urine osmolality predict kidney outcomes. Participants were monitored every six months for five years.
Patients with higher serum osmolality had significantly worse kidney outcomes, with nearly a sixfold higher risk of experiencing a 40% decline in eGFR compared with those with the lowest osmolality levels.
Serum osmolality also showed strong predictive ability for kidney decline. In contrast, urinary osmolality was inversely associated with outcomes and did not perform well as a predictive marker.
Why is this important?
ADPKD therapies often aim to suppress vasopressin signaling, a pathway closely linked to body osmolality and cyst growth. These findings suggest that higher serum osmolality—potentially reflecting higher vasopressin activity—may accelerate kidney function decline in ADPKD.
Because serum osmolality is easy to measure and widely available, it may serve as a practical clinical surrogate for vasopressin activity and help identify patients at higher risk for rapid disease progression, especially where specialized biomarkers such as copeptin are unavailable.
Join us to end the kidney disease epidemic
Most Kidney Stones May Actually Contain Hidden Bacterial Biofilms
This study challenges the long-standing belief that most kidney stones form purely from mineral crystallization. Using advanced electron and fluorescence microscopy, researchers analyzed human calcium oxalate kidney stones—the most common type—and discovered that bacterial biofilms are embedded within their internal structure.
These biofilms were interwoven between mineral layers, forming a complex organic–inorganic composite rather than a purely mineral stone. Some of the bacteria found inside these stones were even culturable, suggesting they remain biologically active.
Areas near bacterial biofilms showed smaller crystal grain sizes, indicating that bacterial components such as extracellular DNA may act as nucleation templates that promote calcium oxalate crystallization.
Why is this important?
The findings suggest that bacteria may play a fundamental role in the formation of calcium-based kidney stones, not just the infection-related struvite stones traditionally associated with bacteria.
If biofilms help initiate or accelerate crystal formation, this could explain why many patients experience recurrent stones and why infections sometimes occur after stone fragmentation procedures.
This work proposes a new conceptual model of kidney stone disease in which microbial activity contributes directly to stone formation, potentially opening the door to microbiome-targeted strategies for preventing recurrent nephrolithiasis.
Calorie Restriction Clears Toxic Uromodulin and Slows Genetic Kidney Disease
This experimental study investigated whether calorie restriction could modify disease progression in autosomal dominant tubulointerstitial kidney disease caused by mutations in the UMOD gene.
In transgenic mice carrying a pathogenic uromodulin mutation, a moderate 30% calorie restriction restored cellular protein-cleanup pathways, particularly autophagy and ER-phagy. This led to reduced accumulation of mutant uromodulin in the endoplasmic reticulum, a key driver of cellular stress in the disease.
As a result, calorie restriction decreased inflammation and fibrosis, improved kidney injury markers, and slowed the decline of kidney function. Notably, the intervention was beneficial both before symptoms developed and in mice with more advanced disease.
Why is this important?
UMOD-related kidney disease is driven by the toxic accumulation of misfolded proteins inside kidney tubular cells. This study shows that calorie restriction directly targets the underlying mechanism by enhancing cellular protein clearance and reducing inflammatory and fibrotic signaling.
These findings highlight metabolic interventions as a potential disease-modifying strategy for genetic kidney disorders and reinforce the broader concept that pathways controlling autophagy and cellular stress responses can influence the progression of chronic kidney disease.
Review article of the month
The Real Kidney Problem in HFpEF Is Fat, Not Filtration
Chronic kidney disease is often said to be common in heart failure with preserved ejection fraction (HFpEF), but this review argues that we have been over-calling “true” kidney disease in this population.
Using the usual CKD cutoff of eGFR <60 mL/min/1.73 m² ignores normal age-related decline in kidney function, and in older adults an age-adjusted threshold closer to <45 may be more appropriate. When you apply that lens, the prevalence of clinically meaningful impairment in HFpEF drops substantially.
The authors also emphasize that heart failure physiology and its treatments can cause reversible changes in creatinine-based eGFR through shifts in kidney perfusion, venous congestion, and intrarenal hemodynamics. This helps explain why progression to end-stage kidney disease in HFpEF is rare, reported as under 0.5% per year, and far lower than the competing risk of death.
The main thesis is that visceral adiposity is the shared upstream driver linking HFpEF with kidney injury, more than hypertension or diabetes alone. Expanded visceral fat promotes neurohormonal activation and an adverse adipokine profile that can directly contribute to sodium avidity, inflammation, glomerular injury, and tubulointerstitial fibrosis, potentially worsened by fat depots around the kidneys.
In contrast, large trials aimed at lowering blood pressure or glucose have not consistently improved hard kidney outcomes in HFpEF, while interventions that reduce visceral adiposity, such as bariatric surgery and GLP-1 receptor agonists, appear to lower risk for both HFpEF and major adverse kidney outcomes.
The review reframes the HFpEF-kidney connection as primarily a metabolic-adiposity problem with cardiorenal manifestations, rather than HFpEF being a common direct pathway to progressive intrinsic kidney failure.
Join here to receive FREE monthly updates on the latest research in Integrative Nephrology and tips on managing kidney disease straight to your inbox.
We would love to hear your feedback. Let us know what you think of these educational materials and if you would like us to focus on specific topics. Please email us at info@inkidney.com.
